Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection 200 mg
DRUG
2 trials
Sponsors
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Conditions
Acute Gout
Gout Arthritis
Phase 2
A Study of SSGJ-613 in Gout Subjects Initiating Urate-Lowering Treatment.
Active, not recruiting
NCT06270225
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Gout Arthritis
Start: 2024-03-30
End: 2024-12-31
Updated: 2024-08-05
Phase 3
A Study of Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection in Chinese Participants With Acute Gout
NCT06169891
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Acute Gout
Start: 2023-12-31
End: 2025-11-30
Target: 500
Updated: 2023-12-14